Literature DB >> 26763025

Vitamin D deficiency and incident stroke risk in community-living black and white adults.

Suzanne E Judd1, Charity J Morgan1, Bhupesh Panwar2, Virginia J Howard3, Virginia G Wadley4, Nancy S Jenny5, Brett M Kissela6, Orlando M Gutiérrez7.   

Abstract

BACKGROUND: Black individuals are at greater risk of stroke and vitamin D deficiency than white individuals. Epidemiologic studies have shown that low 25-hydroxyvitamin D concentrations are associated with increased risk of stroke, but these studies had limited representation of black individuals.
METHODS: We examined the association of 25-hydroxyvitamin D with incident stroke in the Reasons for Geographic and Racial Differences in Stroke (REGARDS) study, a cohort of black and white adults ≥45 years of age. Using a case-cohort study design, plasma 25-hydroxyvitamin D was measured in 610 participants who developed incident stroke (cases) and in 937 stroke-free individuals from a stratified cohort random sample of REGARDS participants (comparison cohort).
RESULTS: In multivariable models adjusted for socio-demographic factors, co-morbidities and laboratory values including parathyroid hormone, lower 25-hydroxyvitamin D concentrations were associated with higher risk of stroke (25-hydroxyvitamin D >30 ng/mL reference; 25-hydroxyvitamin D concentrations 20-30 ng/mL, hazard ratio 1.33, 95% confidence interval (95% CI) 0.89,1.96; 25-hydroxyvitamin D <20 ng/mL, hazard ratio 1.85, 95% CI 1.17, 2.93). There were no statistically significant differences in the association of lower 25-hydroxyvitamin D with higher risk of stroke in black vs. white participants in fully adjusted models (hazard ratio comparing lowest vs. highest 25-hydroxyvitamin D category 2.62, 95% CI 1.18, 5.83 in blacks vs. 1.64, 95% CI 0.83, 3.24 in whites, P(interaction) = 0.82). The associations were qualitatively unchanged when restricted to ischemic or hemorrhagic stroke subtypes or when using race-specific cut-offs for 25-hydroxyvitamin D categories.
CONCLUSIONS: Vitamin D deficiency is a risk factor for incident stroke and the strength of this association does not appear to differ by race.
© 2016 World Stroke Organization.

Entities:  

Keywords:  Stroke; epidemiology; vitamin D

Mesh:

Year:  2016        PMID: 26763025      PMCID: PMC4920062          DOI: 10.1177/1747493015607515

Source DB:  PubMed          Journal:  Int J Stroke        ISSN: 1747-4930            Impact factor:   5.266


  41 in total

1.  Vitamin D3 therapy corrects the tissue sensitivity to angiotensin ii akin to the action of a converting enzyme inhibitor in obese hypertensives: an interventional study.

Authors:  Anand Vaidya; Bei Sun; Carol Larson; John P Forman; Jonathan S Williams
Journal:  J Clin Endocrinol Metab       Date:  2012-04-26       Impact factor: 5.958

2.  N-terminal pro-B-type natriuretic peptide and stroke risk: the reasons for geographic and racial differences in stroke cohort.

Authors:  Mary Cushman; Suzanne E Judd; Virginia J Howard; Brett Kissela; Orlando M Gutiérrez; Nancy S Jenny; Ali Ahmed; Evan L Thacker; Neil A Zakai
Journal:  Stroke       Date:  2014-04-22       Impact factor: 7.914

3.  25-Hydroxyvitamin D levels and the risk of stroke: a prospective study and meta-analysis.

Authors:  Qi Sun; An Pan; Frank B Hu; JoAnn E Manson; Kathryn M Rexrode
Journal:  Stroke       Date:  2012-03-22       Impact factor: 7.914

4.  The reasons for geographic and racial differences in stroke study: objectives and design.

Authors:  Virginia J Howard; Mary Cushman; Leavonne Pulley; Camilo R Gomez; Rodney C Go; Ronald J Prineas; Andra Graham; Claudia S Moy; George Howard
Journal:  Neuroepidemiology       Date:  2005-06-29       Impact factor: 3.282

5.  Racial differences in the impact of elevated systolic blood pressure on stroke risk.

Authors:  George Howard; Daniel T Lackland; Dawn O Kleindorfer; Brett M Kissela; Claudia S Moy; Suzanne E Judd; Monika M Safford; Mary Cushman; Stephen P Glasser; Virginia J Howard
Journal:  JAMA Intern Med       Date:  2013-01-14       Impact factor: 21.873

6.  25-hydroxyvitamin D and symptomatic ischemic stroke: an original study and meta-analysis.

Authors:  Peter Brøndum-Jacobsen; Børge G Nordestgaard; Peter Schnohr; Marianne Benn
Journal:  Ann Neurol       Date:  2012-12-07       Impact factor: 10.422

7.  Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment.

Authors:  H P Adams; B H Bendixen; L J Kappelle; J Biller; B B Love; D L Gordon; E E Marsh
Journal:  Stroke       Date:  1993-01       Impact factor: 7.914

8.  Cardioembolic but not other stroke subtypes predict mortality independent of stroke severity at presentation.

Authors:  Latha Ganti Stead; Rachel M Gilmore; M Fernanda Bellolio; Anunaya Jain; Alejandro A Rabinstein; Wyatt W Decker; Dipti Agarwal; Robert D Brown
Journal:  Stroke Res Treat       Date:  2011-10-10

9.  Lack of aggregation of ischemic stroke subtypes within affected sibling pairs.

Authors:  P G Wiklund; W M Brown; T G Brott; B Stegmayr; R D Brown; S Nilsson-Ardnor; J A Hardy; B M Kissela; A Singleton; D Holmberg; S S Rich; J F Meschia
Journal:  Neurology       Date:  2007-02-06       Impact factor: 9.910

10.  Baseline serum 25-hydroxy vitamin d is predictive of future glycemic status and insulin resistance: the Medical Research Council Ely Prospective Study 1990-2000.

Authors:  Nita G Forouhi; Jian'an Luan; Andrew Cooper; Barbara J Boucher; Nicholas J Wareham
Journal:  Diabetes       Date:  2008-06-30       Impact factor: 9.461

View more
  15 in total

1.  Association of Serum 25(OH) D Levels with Infarct Volumes and Stroke Severity in Acute Ischemic Stroke.

Authors:  Y Y Li; Y-S Wang; Y Chen; Y H Hu; W Cui; X Y Shi; W Jiang; J M Zhang
Journal:  J Nutr Health Aging       Date:  2018       Impact factor: 4.075

2.  Association of 25-hydroxyvitamin D with incident coronary heart disease in the Reasons for Geographic and Racial Differences in Stroke (REGARDS) study.

Authors:  Shejuti Paul; Suzanne E Judd; Virginia J Howard; Monika S Safford; Orlando M Gutiérrez
Journal:  Am Heart J       Date:  2019-08-19       Impact factor: 4.749

3.  Diagnostic performance of bone metabolic indexes for the detection of stroke.

Authors:  Li Ming Tan; Lu Wang; Juan-Juan Chen; Hua Li; Wen-Bo Luo
Journal:  Saudi Med J       Date:  2017-01       Impact factor: 1.484

Review 4.  Lower Vitamin D Status Is Associated with an Increased Risk of Ischemic Stroke: A Systematic Review and Meta-Analysis.

Authors:  Ren Zhou; Mengying Wang; Hui Huang; Wenyong Li; Yonghua Hu; Tao Wu
Journal:  Nutrients       Date:  2018-02-28       Impact factor: 5.717

Review 5.  Vitamin D deficiency and risk of cardiovascular diseases: a narrative review.

Authors:  Babikir Kheiri; Ahmed Abdalla; Mohammed Osman; Sahar Ahmed; Mustafa Hassan; Ghassan Bachuwa
Journal:  Clin Hypertens       Date:  2018-06-22

Review 6.  Vitamin D Deficiency and the Risk of Cerebrovascular Disease.

Authors:  Hyun Ah Kim; Andrea Perrelli; Alberto Ragni; Francesca Retta; T Michael De Silva; Christopher G Sobey; Saverio Francesco Retta
Journal:  Antioxidants (Basel)       Date:  2020-04-17

Review 7.  Vitamin D in Neurological Diseases: A Rationale for a Pathogenic Impact.

Authors:  Rita Moretti; Maria Elisa Morelli; Paola Caruso
Journal:  Int J Mol Sci       Date:  2018-07-31       Impact factor: 5.923

Review 8.  No effects without causes: the Iron Dysregulation and Dormant Microbes hypothesis for chronic, inflammatory diseases.

Authors:  Douglas B Kell; Etheresia Pretorius
Journal:  Biol Rev Camb Philos Soc       Date:  2018-03-25

9.  Association between vitamin D and hypertension in people coming for health check up to a tertiary care centre in South India.

Authors:  Rose Mary J Vatakencherry; L Saraswathy
Journal:  J Family Med Prim Care       Date:  2019-06

10.  Vitamin D deficiency, cardiothoracic ratio, and long-term mortality in hemodialysis patients.

Authors:  Heng-Jung Hsu; I-Wen Wu; Kuang-Hung Hsu; Chiao-Yin Sun; Chun-Yu Chen; Chin-Chan Lee
Journal:  Sci Rep       Date:  2020-05-05       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.